Teva Stock Has More Than Doubled in a Year. Where Will It Be in 3 Years?
· fool.com · popularity 16/100 · 0 similar stories today
Read the original at fool.com →
Summary
Teva's pivot from generics to branded drugs has succeeded, but keep an eye out for this potential headwind. Over the past 12 months, shares in Teva …
Found in: The Motley Fool. Rating basis: single outlet; outlet tier 2 (unlisted); 1 feeds; feed position 17.